RPS Expands European Operations

Europe at a Glance

The European growth of RPS allows clients to utilize the market leading integrated clinical solutions and enhanced full-service capabilities of RPS to develop clinical products beyond the Americas and into Europe for greater value generation across a global R&D pipeline.

Global Solutions with Local Expertise

As the market leader in providing customized integrated and enhanced full service clinical development outsourcing solutions, RPS can now offer clients true global cababilities that span across the Americas and Europe, (Asia expansion planned in 2009).

New European RPS Locations:

• RPS Germany (formerly operating as Imerem), founded in 1990 with headquarters in Nuremberg, Germany.
• RPS Spain (formerly operating as Infociencia), founded in 1998 with headquarters in Barcelona and offices in Madrid, Spain.
• RPS France (formerly operating as Therapharm), founded in 1980 with headquarters in Boulogne Billancourt, France.
  

Additional Areas Currently Covered in Europe:
Austria, Belorussia, Bosnia, Belgium, Bulgaria, Czech Republic, Estonia, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Poland, Portugal, Russia, Romania, Scandinavia, Slovakia, Switzerland, Ukraine, and United Kingdom.

RPS Clients from Europe utilizing the capabilities of RPS in the Americas will recognize the increased value of customized, innovative integrated and full service solutions that are now available globally. Clients in the Americas will also recognize the same value opportunities for their programs which can now leverage the robust experience and capabilities of RPS not only throughout the Americas, but throughout Europe. Regardless of location, the result will be innovative, high quality and robust global capabilities.

RPS European Thought Leaders

The RPS management has a significant track record and extensive experience conducting clinical programs throughout Europe.

• Prof. Dr. Ralf Kohnen, Executive Vice President Clinical Operations, Europe (Germany)
• Antoine Cournot, President, European Business Operations (France)
• Philippe Renout, Managing Director, France
• Peter Windisch, Managing Director, Germany
• Jordi Naval, Managing Director, Spain & Director, Strategic Development, Europe

Significant Highlights and Niche Services

The capabilities of RPS in Europe rise above the many challenges faced by our clients to produce clinical trials generating not just the essential elements of high quality, well-timed clinical projects but using thought leaders that bestow the necessary science, depth and breadth of all regulatory bodies as well as the investigator community, that are so pivotal for a successful program.

Highlights:

• Some of our thought leaders are actively involved in scientific research both in the context of clinical trials and in cooperation with university departments. Thus we are among only a few CROs in the world contributing directly to the progress of science.
• We developed Patient Related Outcome measures to assess symptom severity (pain, sleep, sexual dysfunction, symptoms in specific indications like Restless Legs Syndrome (RLS)), treatment complications (RLS-augmentation) or to evaluate impairment of daily activities and quality of life (chronic venous insufficiency, depression, RLS).
• The application of complex statistical methods like multivariate analyses or neuronal network methodology to clinical data contributes to the exploration of more comprehensive dimensions of disease processes and treatment outcomes.
• Prof. Dr. Ralf Kohnen is author and coauthor of more than 100 publications in high ranking peer-reviewed journals in research areas neurology, psychiatry, and pain.
• The “Survival Guide to Clinical Trials in Spain” is available free of charge.

Services:

Full Service Therapeutic Area Expertise: Over 1,500 full service clinical trials have been conducted across Europe representing every therapeutic area specialty.

We have the capability to conduct full service clinical trials from phase I to phase IV and bring the highest quality standards at every step of the trial: protocol design, monitoring, project management, data management, statistical analysis, reporting, and publications.

Our Nuremberg office (Germany) is the world-wide leading CRO in research in the “Restless Legs Syndrome.”

We have extensive experience in the NeuroSciences area with more than 40 trials conducted over the past 4 years especially in Depression, Parkinson’s Disease, and Restless Legs Syndrome. We also have a relevant expertise in conducting trials in Oncology, Rheumatology, Pain Disorders, Transplantation Medicine and Gastroenterology. (In addition to offering a full breadth of therapeutic area services, more tailored services are also available to support the varying needs of our Clients.)

Phase I Unit: We have an in-patient unit where we are conducting first administration studies (acute or repeated), pharmacokinetics studies, pharmacodynamics studies, bioequivalence studies, food effect studies, dose-ranging studies, (SAD, MAD) on different populations such as healthy volunteers, elderly people, post-menopausal women, Japanese subjects, smoking or non-smoking subjects.

Post-Marketing Studies (PMS), Epidemiological Studies and Surveys: We are performing large-scale PMS, epidemiological studies and surveys with an innovative thinking adapted to the needs of each project and future use of results, with respect of ethics as our main concern.

Patient Education Services: We have developed pioneer trials in controlling blood pressure, weight, asthma or depression symptoms by sending periodical educative text messages..